NDC 69097-867 – Nadolol
Nadolol 20 mg/1 · Tablet · Oral
Product NDC69097-867
Product details
- Brand name
- Nadolol
- Generic name
- Nadolol
- Labeler
- Cipla USA Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA203455
- Marketed since
- February 23, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- beta-Adrenergic Blocker
Active ingredients
- Nadolol 20 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 69097-867-02 | 30 TABLET in 1 BOTTLE (69097-867-02) | Feb 23, 2016 |
| 69097-867-07 | 100 TABLET in 1 BOTTLE (69097-867-07) | Feb 23, 2016 |
| 69097-867-15 | 1000 TABLET in 1 BOTTLE (69097-867-15) | Feb 23, 2016 |
Recalls mentioning this NDC
- D-0464-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Nadolol products
- 50090-7995 Nadolol 20 mg/1 · Tablet · A-S Medication Solutions
- 62332-404 Nadolol 80 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-403 Nadolol 40 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-402 Nadolol 20 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 46708-402 Nadolol 20 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 46708-403 Nadolol 40 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 46708-404 Nadolol 80 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 60687-302 Nadolol 20 mg/1 · Tablet · American Health Packaging
- 60687-887 Nadolol 20 mg/1 · Tablet · American Health Packaging
- 60687-898 Nadolol 40 mg/1 · Tablet · American Health Packaging
- 69238-1124 Nadolol 40 mg/1 · Tablet · Amneal Pharmaceuticals NY LLC
- 69238-1123 Nadolol 20 mg/1 · Tablet · Amneal Pharmaceuticals NY LLC